Proton pump inhibitors, which are used to control acid reflux, are associated with an increased risk for migraine and other severe headache types, new research showed.
The most optimal proton pump inhibitor regimen for histologic response in EoE may be a twice-daily moderate dose, with no additional benefits of a higher dose.
Vonoprazan (Voquezna) is indicated for the healing and maintenance of healing of all grades of erosive esophagitis, as well as relief of associated heartburn in adults.
The risk for a dementia diagnosis before age 90 years was significantly higher among people with a history of PPI use, especially those who were diagnosed at a younger age.